Streetbeat News

Earnings

WMK

Weis Markets reported a decrease in both earnings per share (EPS) and sales for Q4, with EPS dropping to $0.76 from $1.07 year-over-year (YoY) and sales decreasing to $1.21 billion from $1.31 billion YoY.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:47 pm

MTUS

Metallus reported a Q4 2023 EPS of $0.03, a significant improvement from a loss of $(0.75) in the same quarter last year. Net sales also saw a substantial increase, rising to $328.1M from $245.4M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:47 pm

TKO

TKO has provided its financial targets for FY24, projecting revenues between $2.575 billion and $2.65 billion, which is below the estimated $2.79 billion. The company also aims for an Adjusted EBITDA of $1.150 billion to $1.170 billion and a Free Cash Flow Conversion in excess of 50%.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:46 pm

AMBA

Ambarella projects its Q1 revenue to be between $52M and $56M, compared to the estimated $53.59M by analysts.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:42 pm

CRDO

Credo Technology forecasts Q4 revenue to be in the range of $59M-$62M, slightly above the estimated $59.84M. The company anticipates GAAP gross margin between 63.2% and 65.2%, and non-GAAP gross margin between 64.0% and 66.0%.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:41 pm

IMAX

IMAX anticipates its gross box office for 2024 to be similar to the figures reported in 2023, indicating a stable performance outlook for the company.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:40 pm

PTGX

Protagonist Therapeutics reported Q4 2023 earnings of $0.44 per share, surpassing the undefined analyst consensus. Quarterly sales reached $60.00M, exceeding the $40.00M estimate by 50%.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:40 pm

LMAT

LeMaitre Vascular forecasts Q1 EPS of $0.36-$0.41, surpassing the $0.34 estimate, with sales expected between $50.5M-$52.9M, also above the $50.21M estimate. For FY24, the company anticipates an EPS of $1.60-$1.71, exceeding the $1.53 estimate, and sales projections of $209.7M-$214.3M, slightly above the $209.99M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:39 pm

SPCE

Virgin Galactic anticipates Q1'2024 revenue to be around $2M, falling short of the estimated $4.08M. The company expects a free cash flow between $(125) million to $(135) million for the same period. It also announced the 'Galactic 07' spaceflight mission for Q2'2024, the opening of a spaceship factory in Arizona by mid-2024, and confirmed that the production schedule for Delta Class spaceships, aimed for revenue service in 2026, is on track.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:38 pm

MASI

Masimo Corporation projects its FY24 adjusted EPS to be between $3.44 and $3.60, surpassing the estimated $3.32. The company also forecasts revenue to range from $2.045 billion to $2.165 billion, which brackets the $2.103 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:37 pm